NCT06656715Active, not recruiting
Symptom Burden and Health Related Quality of Life of Cancer Patients With Concurrent Heart Failure
Source: ClinicalTrials.gov · Last updated 14 Jul 2026
Brief summary (registry, in English)
To describe and compare the symptom burden in cancer patients with concurrent diagnosis of heart failure (HFrEF compared to HFpEF).
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 102 (actual)
- First submitted
- 11 Oct 2024
- Start date
- 16 Dec 2024
- Primary completion date
- 1 Sept 2026
- Lead sponsor
- M.D. Anderson Cancer Center
- Diseases
- Heart failure
- NCT number
- NCT06656715
What you commit to
- Study type: Observational
- Participants enrolled: 102
- From 16 Dec 2024 to the primary completion date, 1 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Participants undergoing active cancer treatment.
Other
- Inability to provide consent in the medical record, such as cognitively impaired individuals.
Who the study is looking for
- Age 18 years and older
- Individuals with a concurrent solid tumor cancer diagnosis
- Not receiving active cancer treatment except for those on maintenance (i.e., Selective ER modulators (SERMs)\[Tamoxifen\], Aromatase inhibitors (Anastrozole, Letrozole, Exemestane), Ovarian suppression therapy (GnRH Agonists \[Leuprolide\], Androgen deprivation therapy for prostate cancer
- Completed cancer treatment at least 3 months and up to 3 years before study enrollment.
- Therapy
- Able to read, speak and consent in English
- Ability to understand and the willingness to sign a written informed consent document
- Diagnosis of heart failure, confirmed by echocardiogram, MUGA, or cardiac catheterization
- Internet access via smart phone, tablet, a computer, or another device with the capacity to 1) download the Fitbit App and 2) complete electronic study assessments via REDCap.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The University of Texas of MD Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.